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Mammaglobin in Normal Human Sweat Glands and Human
Sweat Gland Tumors
To the Editor:
We have found prominent mammaglobin expression in normal
human sweat glands, and an apparent downregulation in sweat
gland tumors. The mammaglobin gene was originally identi¢ed
in a screen for human breast-cancer-associated genes (Watson and
Fleming, 1996). Mammaglobin is a member of the secretoglobin
superfamily, which also includes uteroglobin (Clara cell protein;
Clara cell 10 kDa protein), lymphoglobin, and the lipophilins A,
B (BU101), and C (lacryglobin; mammaglobin B) (Klug et al,
2000). In human breast tissue, mammaglobin is secreted as a gly-
cosylated peptide, which is covalently associated with lipophilin
B (Colpitts et al, 2001). There is today no established function for
mammaglobin or the lipophilins. Uteroglobin, however, is
known to possess anti-in£ammatory activities, interact with ¢-
bronectin, and, possibly, be involved in IgA nephropathy and in
the development of prostate cancers (reviewed in Mukherjee et al,
1999). Mammaglobin expression has been claimed to be breast
tissue speci¢c and con¢ned to the mammary glands (Watson
and Fleming, 1996;Watson et al, 1999). Recently, however, mam-
maglobin RNA has been reported to be ampli¢ed by RT-PCR
also from nonbreast tissues (Lehrer et al, 1998; Carter et al, 2002;
O’Brien et al, 2002; Zehentner et al, 2002).
Using a highly speci¢c and quantitative real-time RT-PCR
protocol, we analyzed the expression of mammaglobin mRNA
and 18S rRNA in 25 di¡erent normal human tissues (Table I).
The highest mammaglobin mRNA levels were, surprisingly,
not found in the breast tissue, but rather in the skin (Table I).
The omission of reverse transcriptase from the RT-PCR resulted
in no detectable signals, showing that the signals were not due to
contaminating DNA (data not shown).
We then assessed the cellular distribution of mammaglobin
mRNA by in situ hybridization. Punch biopsies of normal skin
from the gluteus area were snap frozen in liquid nitrogen and
cryostat sections were made. The in situ hybridization demon-
strated that cells in the secretory coil of the eccrine sweat glands
were expressing mammaglobin mRNA (Fig 1a). Other skin
cells, including the cells in epidermis, were found to be negative
for mammaglobin mRNA (Fig 1a, and data not shown). Due to
the lack of frozen apocrine biopsies, apocrine sweat glands were
not analyzed by in situ hybridization.
Immunohistochemical analyses were carried out using a⁄nity-
puri¢ed rabbit antibodies against a synthetic peptide corres-
ponding to the 16 amino acids of the COOH terminus of mam-
maglobin (1 mg per ml, AgriSera, Vnns, Sweden). Analysis of
para⁄n-embedded sections of normal skin from the gluteus area
showed strong cytoplasmic immunostaining of cells in the ec-
crine sweat glands (Fig 2a). It was primarily the coiled gland cells
that stained for mammaglobin, whereas the ductal cells appeared
negative or stained very weakly. In addition, mammaglobin
staining was seen in the lumen of some ducts (Fig 2a). There
was no di¡erence in the staining intensity between samples from
male and female (data not shown). In the apocrine glands, a few
scattered cells showed strong mammaglobin staining, but the
majority of cells appeared negative (Fig 2b). Staining was also
seen in the lumen of some apocrine glands (Fig 2b). In cylindroma,
Table I. Expression levels of mammaglobin (MGB) mRNA in
human tissuesa
Tissueb MGB (103)c MGB/18Sd
Skin 13,433 41,178
Mammary gland 2,879 10,000
Uterus 776 4,043
Salivary glands 266 1,735
Kidney 26 125
Testis 19 68
Cervix 16 120
Prostate 8 26
Trachea 8 26
Ovary 7 36
Thyroid 3 5
aQuantitative real-time RT-PCR was performed essentially as described pre-
viously (Nilsson et al, 2001). RNA samples purchased from Clontech Laboratories
(Palo Alto, CA), OrigeneTechnologies (Rockville, MD), Stratagene (La Jolla, CA),
and Ambion (Austin, TX) were run in triplicate using 200 ng of DNase-treated
total RNA from respective tissues. For mammaglobin, the primers used were 50 -
CAAGACAATCAATCCACAAGTGTCTAAGAC-30 and 50 -CAGAGTTTCAT-
CCGTTTGGTTAAGAAAACATTC-30, and the probe used was 50 -fTTCATCT-
qATGGCATTTGTAGTGGCATTGTCGTCTATGAACTCTTGAAGAAG-30, where
f T denotes a £uorescein conjugated to the 50 -thymidine and Tq denotes a thymidine
with a conjugated Dark Quencher molecule. Quanti¢cationwas performed by compar-
ring the threshold cycle values (Ct) for the samples with standard curves gener-
ated using in vitro transcribed mammaglobin RNA and 18S rRNA plasmid DNA,
respectively.
bAdditional tissues analyzed were adrenal gland, bladder, blood, brain, colon,
heart, liver, lung, pancreas, placenta, skeletal muscle, small intestine, spleen, and
stomach, which all expressed less than 103 mammaglobin mRNA copies per mi-
crogram of total RNA.
cCopies of mammaglobin mRNA per microgram of total RNA.
dRelative ratio of mammaglobin mRNA and 18S rRNA, in arbitrary units.
Figure1. Cellular localization of mammaglobin mRNA. Cryostat
sections of human skin were subjected to in situ hybridization for mamma-
globin mRNA. DIG-labeled antisense probe (a) and, as a negative control,
DIG-labeled sense probe (b) were hybridized to sections of human skin
with a ¢nal probe concentration of 1 mg per ml (Roche Diagnostics, Brom-
ma, Sweden). The sections were visualized using horseradish peroxidase
conjugated anti-DIG antibodies and NBT/BCIP substrate. Scale bar: 50 mm.
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a benign sweat gland tumor, four out of ¢ve tumors showed lack
of mammaglobin immunostaining (Fig 2c). In one cylindroma a
few small groups of cells showed positive immunostaining (Fig
2d). Immunohistochemical staining of an apocrine hidrocystoma,
a cystic dilated apocrine sweat gland, showed, like the apocrine
sweat gland, some scattered cells with strong cytoplasmic immu-
noreactivity whereas most of the cells had a weak cytoplasmic
staining (Fig 2e). Immunohistochemical staining of a hidradeno-
ma papilliferum, a secreting tumor derived from the apocrine
sweat gland, also showed scattered cells with strong cytoplasmic
staining. Most of the mammaglobin-positive cells showed a weak
to moderate cytoplasmic staining, but there were also glands that did
not stain. In some of the glands, the lumen also stained (Fig 2f).
The function of mammaglobin is not established, but from the
¢ndings reported herein it can be speculated that mammaglobin
has a role in the function of human sweat glands. Mammaglobin
might, for example, as has been suggested for other secretoglo-
bins, be required for the function of the secretory machinery
(Stripp et al, 1996), function as carrier of hydrophobic molecules
such as hormones (Mukherjee et al, 1999) and pheromones
(Alvarez et al, 2002), or function as an immunomodulator (Mu-
kherjee et al, 1999).The lack of mammaglobin expression in cylin-
dromas could also implicate a tumor-suppressive function. In
prostate cancer, downregulation of uteroglobin expression corre-
lates with increasing tumor grade (Weeraratna et al, 1997), and
overexpression or exogenous addition of uteroglobin reverses
the transformed phenotype of cancer cells (Mukherjee et al,
1999). On the other hand, mammaglobin is expressed in the ma-
jority of human breast cancers, and more than 10-fold overex-
pressed in one-fourth of these tumors (Watson and Fleming,
1996;Watson et al, 1999). These seemingly contradictory observa-
tions might be reconciled if mammaglobin has di¡erent func-
tions in di¡erent tissues and tumors. A de¢nitive answer to the
question of whether mammaglobin functions as a tumor suppres-
sor in the sweat glands (and in other tissues), however, will re-
quire evidence from tumor models where the mammaglobin
levels can be experimentally manipulated. In conclusion, in this
study we have demonstrated prominent mammaglobin expres-
sion in human sweat glands, and an apparent downregulation in
cylindroma sweat gland tumors. We also showed expression of
mammaglobin mRNA in several additional nonbreast tissues.
These ¢ndings will have to be considered in future studies aim-
ing at establishing the physiologic role of this protein.
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Figure 2. Mammaglobin immunoreactivity in normal human sweat glands and sweat gland tumors. Para⁄n-embedded sections were labeled
using anti-mammaglobin peptide antibody followed by a horseradish peroxidase conjugated secondary antibody, and diaminobenzidine substrate. Cell
nuclei were counterstained using hematoxylin.White arrows indicate the secretory segment, and black arrows indicate the duct segment, as determined by
serial sectioning and hematoxylin and eosin staining of adjacent sections (not shown). Eccrine sweat gland (a). Apocrine sweat gland (b). Mammaglobin
nonexpressing cylindroma (c). Mammaglobin-expressing cylindroma (d ). Apocrine hidrocystoma (e). Hidradenoma papilliferum ( f ). Scale bar: 100 mm.
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